A molecular approach to the classification of von Willebrand disease

被引:39
作者
Schneppenheim, R
Budde, U
Ruggeri, ZM
机构
[1] Univ Hamburg Hosp, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany
[2] Lab Assoc Keeser Arndt & Partners, Coagulat Lab, D-22339 Hamburg, Germany
[3] Scripps Res Inst, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Div Expt Hemostasis & Thrombosis, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
关键词
von Willebrand disease; von Willebrand factor; classification; molecular genetics; multimers; von Willebrand disease type 2;
D O I
10.1053/beha.2001.0134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The marked heterogeneity of von Willebrand disease was already recognized by von Willebrand in 1926. The accumulating knowledge of the different clinical phenotypes and the pathophysiological basis of the disease was translated into a classification that differentiated between quantitative and qualitative defects by means of quantitative and functional parameters and by analysing the electrophoretic pattern of von Willebrand factor multimers. The increasing number of different von Willebrand disease phenotypes required a revision of the nomenclature at a time when only a few types of von Willebrand disease had already been analysed at the molecular level. Consequently, the molecular data played only a minor role in the revised classification. Given the pronounced, even intra-individual, variation in the manifestation of von Willebrand disease and the diagnostic difficulties caused by a non-standardized methodology, it is clear that biochemical methods alone are insufficient for a clear classification. The advent of molecular techniques provided the opportunity for genotype-phenotype studies that recently helped to elucidate or confirm not only the important functions of von Willebrand factor and the steps of its post-translational processing, but also many disease-causing defects. The reproducible correlation between certain phenotypes and particular mutations can now be used for a molecular approach towards a final classification of von Willebrand disease, equally useful for the clinician and for research requirements.
引用
收藏
页码:281 / 298
页数:18
相关论文
共 75 条
[1]  
Allen S, 2000, BLOOD, V96, P560
[2]   Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor [J].
Allen, S ;
Abuzenadah, AM ;
Blagg, JL ;
Hinks, J ;
Nesbitt, IM ;
Goodeve, AC ;
Gursel, T ;
Ingerslev, J ;
Peake, IR ;
Daly, ME .
BLOOD, 2000, 95 (06) :2000-2007
[3]   A STOP CODON IN A PATIENT WITH SEVERE TYPE-III VONWILLEBRAND DISEASE [J].
BAHNAK, BR ;
LAVERGNE, JM ;
ROTHSCHILD, C ;
MEYER, D .
BLOOD, 1991, 78 (04) :1148-1149
[4]   AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN [J].
BROWN, JE ;
BOSAK, JO .
THROMBOSIS RESEARCH, 1986, 43 (03) :303-311
[5]  
CACHERIS PM, 1991, J BIOL CHEM, V266, P13499
[6]   A NEW VARIANT OF VONWILLEBRAND DISEASE (TYPE-II TYPE-I) WITH A NORMAL DEGREE OF PROTEOLYTIC CLEAVAGE OF VONWILLEBRAND-FACTOR [J].
CASTAMAN, G ;
RODEGHIERO, F ;
LATTUADA, A ;
MANNUCCI, PM .
THROMBOSIS RESEARCH, 1992, 65 (03) :343-351
[7]  
CIAVARELLA G, 1985, BLOOD, V66, P1423
[8]   THE MOLECULAR DEFECT IN TYPE-IIB VONWILLEBRAND DISEASE - IDENTIFICATION OF 4 POTENTIAL MISSENSE MUTATIONS WITHIN THE PUTATIVE GPLB BINDING DOMAIN [J].
COONEY, KA ;
NICHOLS, WC ;
BRUCK, ME ;
BAHOU, WF ;
SHAPIRO, AD ;
BOWIE, EJW ;
GRALNICK, HR ;
GINSBURG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1227-1233
[9]   IDENTIFICATION OF A CLEAVAGE SITE DIRECTING THE IMMUNOCHEMICAL DETECTION OF MOLECULAR ABNORMALITIES IN TYPE-IIA VONWILLEBRAND-FACTOR [J].
DENT, JA ;
BERKOWITZ, SD ;
WARE, J ;
KASPER, CK ;
RUGGERI, ZM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6306-6310
[10]  
EIKENBOOM JCJ, 1992, THROMB HAEMOSTASIS, V68, P448